The highest patient volumes in procedural medicine, a biopsy-result call behind half of them, and a Mohs schedule that runs like an OR.
Dermatology practices book more visits per provider than nearly any specialty, and the phone reflects it: new-patient waits measured in months, recall queues, and a steady stream of patients calling about biopsy results. Result calls carry the same discipline problem everywhere: status is shareable, findings are not. Add Mohs day logistics, isotretinoin program windows with hard monthly deadlines, and post-procedure bleeding questions, and the phone becomes the practice's rate limiter.
Caller I had a biopsy taken from my back last week and nobody has called me. I'm getting nervous.
ClinicFlow I understand completely, and I can check the status right now. Can I confirm your name and date of birth?
Caller Elaine Brodsky, 7/7/1966.
ClinicFlow Thank you, Elaine. I can see your pathology has come back and is with Dr. Marsh for review. Results are always discussed with you by the clinical team rather than over this line, so I've flagged your call and someone will reach you within a day. Would you like me to also book the follow-up visit where Dr. Marsh goes over everything with you?
Caller Yes, please, as soon as possible.
ClinicFlow She has Thursday at 11:40 AM or next Monday at 2:20 PM. Which works better?
Status is shared, findings never are; the waiting patient is flagged to the clinical team, and the review visit books on the same call.
New-patient, recall, full-body-exam, and cosmetic consult scheduling into the correct visit types, at dermatology's pace.
Arrival waves, duration expectations, and day-before instructions per your protocols, plus post-Mohs bleeding screening on your criteria.
Isotretinoin-program calls captured with their monthly-window urgency flagged to your team, never buried in voicemail.
| Scenario | Destination |
|---|---|
| Post-procedure bleeding, spreading infection, severe medication reactions | Escalated per your criteria, urgent pathways honored |
| Biopsy status inquiries | Status shared, team flagged, review visit booked; findings never disclosed |
| Scheduling: new patients, recalls, exams, cosmetic consults | Booked in the EMR |
Surgical-day coordination, staged-case expectations, and post-op bleeding screening per your surgeons' criteria.
Recall queues and isotretinoin program windows kept on schedule with flagged urgency.
Consult inquiries answered instantly and booked before the caller dials the next practice.
Result-status calls handled with the status-versus-findings line held on every call.
No. It shares workflow status only: received, under review, discussed at your visit. Findings are always delivered by your clinical team. The AI flags waiting patients so callbacks get prioritized, and books the review visit on the same call.
It books to your real availability, offers waitlist capture where you configure it, and never overpromises. Practices use it to keep every inquiry captured even when the next routine slot is months out.
Program calls are captured with the monthly-window context flagged, so your team can act inside the compliance window rather than discovering the call after it closed.
The demo line is the production agent. Describe a scenario from this page and judge for yourself.
